Startup · $2.8m raised
Adelaide, SA
Every investor coverage indicates participated in a round Fertilis raised.
| Investor | Rounds | Invested |
|---|---|---|
| Horizons Ventures | Seed | - |
Companies Fertilis acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Marty Gauvin | CEO · Founder | Forbes Australia, TechCrunch Australia |
| Professor Jeremy Thompson | Chief Scientific Officer · Founder | Forbes Australia, TechCrunch Australia |
Stories naming Fertilis. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
TechCrunch's daily roundup leads with Brex's $300 million Series D-2 at a $12.3 billion valuation plus a Meta executive hire, Kleiner Perkins closing $1.8 billion across two funds, and several other startup raises.
Adelaide IVF device startup Fertilis secured a seed round led by Horizons Ventures to advance clinical trials and commercialise its embryo-culturing cradle devices.
Also Forbes Australia